2月23日周末公告汇总 | 润泽科技拟购买广东润惠深化AIDC业务整合；宗申动力筹划与隆鑫通用进行重大资产置换

Group 1: Resumption of Trading - Yongtai Technology has terminated the purchase of 25% equity in Yongtai High-tech from CATL, leading to the resumption of its stock trading [1] - Runze Technology plans to acquire 42.56% equity in Guangdong Runhui through a convertible bond issuance, further integrating IDC and AIDC business resources, resulting in stock resumption [1] Group 2: Capital Increase and Restructuring - Zongshen Power intends to swap its motorcycle engine business with Longxin General's general machinery business, which is expected to constitute a major asset restructuring [2] - Nanjing Chemical Fiber plans to acquire 100% equity in Nanjing Craft through asset swaps, share issuance, and cash payments [3] - Southwest Securities plans to raise no more than 6 billion yuan through a private placement [4] Group 3: Equity Transfer and Buyback - Hemai Co., Ltd. has a planned agreement to transfer 5.99% equity from Hainan Xinhai [5] - Luxshare Precision has conducted its first share buyback of 9.9 million shares, with a total transaction amount of nearly 500 million yuan [6] Group 4: External Investment and Daily Operations - Gaode Infrared has signed a contract for a complete equipment system worth 1.851 billion yuan, accounting for 69% of its audited revenue for 2024 [7] - Shenghong Technology now holds 100% equity in SPMY, with the target company becoming its FPC/PCB production base in Malaysia [7] - BGI Genomics plans to sell 100% equity in Complete Genomics for 50 million USD and adjust the licensing of CoolMPS sequencing technology [8] - Aolian Electronics' controlling shareholder, Ruiying Assets, has terminated the control transfer with Chaocheng Innovation [9] - Frontier Biotech has signed a licensing agreement with GlaxoSmithKline, receiving a 40 million USD upfront payment and 13 million USD in milestone payments [9] - Baili Tianheng's clinical trial for iza-bren (EGFR×HER3 dual antibody ADC) for locally advanced or metastatic triple-negative breast cancer has reached its primary endpoint in interim analysis [9] - Donghong Co., Ltd. has won a procurement project for pressure steel pipes and accessories worth 353 million yuan [10] - ST Xintong's subsidiary has signed a server procurement contract worth 400 million yuan [11] Group 5: Performance Changes - Yingshi Innovation expects a net profit of 964 million yuan in 2025, a year-on-year decrease of 3.08% [12]